Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1992-01-29
1993-11-23
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
552601, 552602, A61K 3156
Patent
active
052644278
ABSTRACT:
Novel 20-substituted-pregnene derivatives, compositions containing such derivatives and methods for their use and manufacture are disclosed. The 20-substituted-pregnene derivatives inhibit the androgen biosynthesis enzymes 17(alpha)-hydroxylase/C.sub.17,20 -lyase and 5(alpha)-reducatase and are therefore useful for reducing or inhibiting production of androgens where they have an adverse role in a disease or physiological condition in vertebrate species.
REFERENCES:
Krause, et al. Steroids, 31(6) pp. 823-839 (1978).
Li et al., J. Steroid Biochem. Molec. Biol., 42: 313-320 (1992).
Brodie Angela
Li Jisong
Cintins Marianne M.
Kestler Kimberly J.
Research Corporation Technologies Inc.
LandOfFree
20-substituted pregnene derivatives and their use as androgen sy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 20-substituted pregnene derivatives and their use as androgen sy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 20-substituted pregnene derivatives and their use as androgen sy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849004